10 results
8-K
MIRA
Mira Pharmaceuticals Inc
19 Jul 24
Other Events
5:12pm
with the mu-opioid receptor, unlike traditional ketamine. This could potentially mean a reduced risk of opioid-related side effects and dependency.
Building
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
of these receptors can lead to sedative effects, which is consistent with the tranquilizing effects that ketamine can produce.
Sigma Opioid Receptor … of ketamine. Here’s how ketamine’s interaction with sigma opioid receptors might contribute to its dissociative side effects:
Cognitive and Perceptual
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
of patient and prescription growth. Opioid toxicity and related annual deaths suggest a novel non-opioid pain killer is needed.
Our initial focus … , and pain associated with aging (e.g. joint pain) are among the key drivers of patient and prescription growth. Opioid toxicity and related annual
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
neuropathy, and pain associated with aging (e.g. joint pain) are among the key drivers of patient and prescription growth. Opioid toxicity and related … annual deaths suggest a novel non-opioid pain killer is needed.
Our initial focus will be a dual path: potentially winning in traditional markets
S-1
tyx 4m59ne
29 Jun 23
IPO registration
4:39pm
DRS/A
8fidm3n xagi
8 Jun 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next